Molecular Medicine 2015

Biomarkers For Bone Tumors: Discovery From Genomics And Proteomics Studies And Their Challenges

Wan I Wan-Ibrahim, Vivek A Singh, Onn H Hashim, and Puteri S Abdul-Rahman

Diagnosis of bone tumor currently relies on imaging and biopsy, and hence, the need to find less invasive ways for its accurate detection. More recently, numerous promising deoxyribonucleic acid (DNA) and protein biomarkers with significant prognostic, diagnostic and/or predictive abilities for various types of bone tumors have been identified from genomics and proteomics studies. This article reviewed the putative biomarkers for the more common types of bone tumors (that is, osteosarcoma, Ewing sarcoma, chondrosarcoma [malignant] and giant cell tumor [benign]) that were unveiled from the studies. The benefits and drawbacks of these biomarkers, as well as the technology platforms involved in the research, were also discussed. Challenges faced in the biomarker discovery studies and the problems in their translation from the bench to the clinical settings were also addressed.

View PDF
Posted by Sheila Platt on Feb 25, 2016 12:38 PM CST